[Does fenfluramine mean a real advance in the treatment of obesity?].
D000284:Administration, Oral; D000661:Amphetamine / Q000627:therapeutic use; D000818:Animals; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D004285:Dogs; D005069:Evaluation Studies as Topic; D005260:Female; D005277:Fenfluramine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use* / Q000633:toxicity; D000882:Haplorhini; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009765:Obesity / Q000188:drug therapy*; D010919:Placebos; D011817:Rabbits; D051381:Rats
D010919:Placebos; D005277:Fenfluramine; D000661:Amphetamine
Fenfluramina, czy istotnie postep w leczeniu otyłości.